Johan Spoor

Johan M.
Spoor was the founder of GridAI Technologies Corp., founded in 2014, where the title held was Director from 2019 to 2020.
Current jobs include President, Chief Executive Officer & Director at FluoroPharma, Inc. since 2011; Chief Executive Officer & Director at Perspective Therapeutics, Inc. since 2023; Independent Director at AtheroNova, Inc. since 2012; and Director at AeacusBio.
Former jobs include Chief Executive Officer & Director at IsoRay, Inc.; Chief Executive Officer at Viewpoint Molecular Targeting, Inc. from 2022 to 2023; President & Chief Executive Officer at KBP Biosciences USA, Inc. from 2019 to 2021; Director at Photovoltaic Solar Cells, Inc. in 2012; Director at Verifi Water, Inc. from 2017 to 2023; Director at FluoroPharma Medical, Inc. in 2015; Independent Director at Protea Biosciences Group, Inc. in 2014; Independent Director at MetaStat, Inc. from 2015 to 2016; Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2005 to 2007; Research Analyst at JPMorgan Securities LLC from 2007 to 2008; and Chief Financial Officer at Sunstone Biosciences, Inc. Education includes an undergraduate degree from the University of Toronto in 1994 and an MBA from Columbia Business School.